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Susceptibility to environmental carcinogenesis is the consequence of a complex interplay
between intrinsic hereditary factors and actual exposures to potential carcinogenic agents. We
must learn the nature of these interactions as well as the genetic defects that confer enhanced
risk. In some genetic diseases an increased cancer risk correlates with a defect in the repair or
replication of damaged DNA. Examples include xeroderma pigmentosum (XP), ataxia telangiectasia,
Fanconi's anemia, and Bloom's syndrome. In Cockayne's syndrome the specific defect in
transcription-coupled repair (TCR) does not predispose the patients to the sunlight-induced skin
cancer characteristic of XP. The demonstration of TCR in the XP129 partial revertant of XP-A cells
indicates that ultraviolet (UV) resistance correlates with repair of cyclobutane pyrimidine dimers in
active genes. Repair measured as an average over the genome can be misleading, and it is
necessary to consider genomic locations of DNA damage and repairfor a meaningful assessment
of the biological importance of particular DNA lesions. Mutations in the p53 tumor suppressor
gene are found in many human tumors. TCR accounts for the resulting mutational spectra in the
p53 gene in certain tumors. Li-Fraumeni syndrome fibroblasts expressing only mutant p53 are
more UV-resistant and exhibit less UV-induced apoptosis than normal human cells or heterozygotes
for mutations in only one allele of p53. The p53-defective cells are deficient in global excision
repair capacity but have retained TCR. The loss of p53 function may lead to greater genomic
instability by reducing the efficiency of global DNA repair while cellular resistance may be assured
through the operation of TCR and the elimination of apoptosis. Environ Health Perspect
104(Suppl 3):547-551 (1996)
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Introduction
The biological consequences ofunrepaired
or misrepaired DNA damage depend upon
the precise locations ofthe lesions. DNA
lesions at specific sites in the mammalian
genome can lead to mutation, recombina-
tion, gene amplification, translocation, and
other chromosomal abnormalities. These
changes in turn may result in malignant
transformation, faulty differentiation
patterns, or cell death. Thus, it has become
clear that damage to DNAat particular loci
can cause activation ofthe protooncogenes
and inactivation oftumor suppressor genes
that may be implicated in subsequent
tumorigenesis (1). An increased incidence
ofneoplasia is correlated with a defect in
the repair or replication ofdamaged DNA
in some human genetic diseases. Examples
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ofsuch hereditary disorders include xero-
derma pigmentosum (XP), ataxia telangiec-
tasia (AT), Fanconi's anemia (FA), and
Bloom's syndrome (BS) but not Cockayne's
syndrome (CS). In the cases ofXP and CS,
the cultured cells derived from the patients
are hypersensitive to short wavelength
ultraviolet light (UV), but onlyforXP does
the sunlight sensitivity lead to multiple
skin cancers (2). In Li-Fraumeni syndrome
(LFS), the patients inherit a germ-line
defect in one allele ofthe p53 tumor sup-
pressor gene, resulting in increased neo-
plastic potential. The loss of the second
allele and consequent loss of functional
p53 has profound consequences (3),
including excision repair deficiency in the
overall genome as discussed below.
Until recently there has been little
information on the fine structure ofDNA
lesions and their repair in the mammalian
genome because the available methodology
did not provide such information. Hoping
to understand some ofthe biological phe-
nomena that result from DNA-damaging
treatments, my colleagues and I have
focused our research in the past decade
upon the intragenomic fine structure of
DNA damage processing in mammalian
cells. It was ofparticular interest to under-
standwhy cellular sensitivity to agents such
as UV does not always correlate with mea-
sured efficiencies of DNA repair. A classic
example is the comparison ofthe UV sensi-
tivities ofhuman versus rodent cells and
their corresponding DNA repair efficien-
cies. While human and mouse fibroblasts
in culture exhibit similar UV survival char-
acteristics, their repair efficiencies are quite
different. Within 24 hr after a low UV
dose, human cells remove most of the
cyclobutane pyrimidine dimers (CPD), the
predominant lesion produced, while the
rodent cells remove less than 20% (4). The
rodent cells may achieve high survival by
selective repair of their essential active
genes in spite of their low overall repair
efficiencies. Experiments that document
preferential DNA repair in active genes
support this explanation (5-9).
Ifone considers the various functional
domains ofthe genome and the potential
consequences of unrepaired damage in
those regions, actively transcribed genes
would appear to be particularly at risk. It is
well known that bulky DNA lesions such
as CPD pose blocks to the process oftran-
scription in vivo and in vitro (10,11).
Incomplete RNA transcripts are produced
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from a gene containing one or more CPD
in its transcribed strand. Persisting damage
in silent genomic domains may be ofless
consequence unless it results in accumulating
errors in genes that might be expressed at a
later stage in the cellular history. Ofcourse
gross chromosomal rearrangements result-
ing from such damage may also seriously
affect cellular growth regulation. Damage
near replication origins could either block
initiation ofreplication at those origins or
distort the cell cycle control ofthe initia-
tion of replication, possibly resulting in
gene amplification. Damage encountered
by replication forks may have quite differ-
ent consequences depending upon whether
the lesions are in the leading or the lagging
DNA strand. While some types ofdamage
such as interstrand cross-linkage would
block replication by preventing parental
strand separation, others like 06 alkylation
on guanine may simply alter the coding
properties at the site ofchain growth. To
understand in detail the role ofDNA func-
tion on biological consequences ofdamage,
it is necessary to measure the lesions and
their repair in specific DNA sequences
within relevant genomic domains.
Methodology
Traditional methods that have been used
to measure DNA damage and repair in
cells do not reveal intragenomic hetero-
geneity in the distribution of lesions or
repair patches (5). To measure damage in
different specific DNA sequences within
cells, the sequences of interest must either
be isolated directly for analysis or, prior to
hybridization probing for the sequences of
interest, some partitioning scheme must
be employed to distinguish those DNA
fragments containing one or more lesions
from those with no lesions. Using the latter
approach, a versatile technique was devel-
oped that can be applied to any DNA
sequence for which specific hybridization
probes are available (6).
In the prototype experiments, a Chinese
hamster ovary (CHO) cell line carrying a
50-fold amplification ofthe dihydrofolate
reductase (DHFR) gene was used to
enhance the sensitivity of detection of a
restriction fragment within the gene when
the appropriately restricted DNA was elec-
trophoresed under denaturing conditions
(6). The bacteriophage T4 endonuclease V
(TEV) was used as a specific nicking agent
for CPD because it cuts the damaged
DNAstrands at the site ofeach CPD in the
duplex DNA but does not respond to other
lesions. Any restriction fragment containing
one or more CPD is cleaved by the enzyme
so the affected strands would not appear in
the electrophoretic gel at the position of
the intact fragments. The DNA restriction
fragment bands, upon Southern transfer to
a nylon membrane, were detected by
hybridization with 32P-labeled genomic or
c-DNA probes. The proportion of frag-
ments free ofendonuclease-sensitive sites
in each sample (the zero class) was then
determined from the ratio of the amount
ofprobe hybridized at the band position of
full-length fragments for the TEV-treated
and untreated samples. It is important that
the DNA to be analyzed does not include
replicated DNA because that would add to
the zero class; therefore, density labeling of
the replicating DNA with 5-bromodeoxy-
uridine is used, followed by CsCl equilib-
rium density gradient centrifugation to
separate the unreplicated parental DNA
from hybrid daughter DNA. In principle,
any type of damage for which specific
strand nicking at lesion sites can be accom-
plished may be quantified in this way.
Thus, the UVRABC repair endonuclease
enzyme complex from Escherichia coli has
been used to quantify bulky lesions pro-
duced by cis-platinum, psoralen, and
4-nitroquinoline oxide as well as UV (12).
It has also been used to quantify amino-
fluorene adduct formation and repair in
specific DNA sequences (13). To investi-
gate the repair of methylated bases, a
quantitative method was developed that
involves treating the DNA with an appro-
priate restriction enzyme and then heating
it to release N-methylpurines (14). One
portion ofeach sample serving as control is
heated in the presence ofmethoxyamine to
reduce the apurinic sites and protect them
from subsequent alkaline degradation.
Following alkaline hydrolysis, electro-
phoresis, transfer to a membrane, and
probing for the fragment of interest, the
ratios of the band intensities of the DNA
sample not treated with methoxyamine to
its methoxyamine-treated counterpart are
calculated to yield the percentage of
the restriction fragments containing no
alkaline-labile sites. A procedure was also
developed for quantifying psoralen pho-
toadducts in specific DNA sequences,
based upon the resolution of DNA frag-
ments containing one or more interstrand
cross-links (15). The cross-links are deter-
mined in renaturing neutral gels while the
cross-linkable monoadducts are indirectly
quantified by a procedure in which the iso-
lated DNA is reirradiated to convert the
maximum number of monoadducts to
cross-links prior to analysis on neutral gels.
These methods have been described in
cookbook detail for different cellular
systems and applications (16-18).
Repair of CPD in
Protooncogenes
Protooncogenes are among the most impor-
tant cellular targets ofphysical and chemi-
cal carcinogens. Thus, the activation ofthe
H-ras protooncogene has been shown to be
due to DNA damage produced by carcino-
gens rather than as a secondary conse-
quence oftransformation. The removal of
DNA lesions from protooncogenes at risk
could therefore represent a critical step in
the prevention oftumorigenesis.
As a model system, we used UV-irradi-
ated Swiss mouse 3T3 fibroblasts to com-
pare in the same experiment the formation
and removal of CPD in two protoonco-
genes, the actively transcribed ABL gene
and the transcriptionally silent MOS gene
(19). Confluent cultures were irradiated
with a UV dose of 20 J/m2, and one por-
tion was lysed immediately while the other
was incubated for 24 hr to allow repair.
The appropriately restricted DNA samples
were either treated or mock treated with
TEV prior to electrophoresis, Southern
transfer, and hybridization with an ABL or
a MOS probe. Similar CPD frequencies
were found in the two genes initially, but
there were marked differences by 24 hr.
Substantial repair occurred in the ABL
gene, while little repair was detected in the
MOS gene. These results lead to the gen-
eral prediction that more UV-induced
mutations should accumulate in the MOS
region and in other silent domains than
in the ABL gene in these cells. While one
cannot draw conclusions about the specific
role of protooncogene repair in relation
to tumorigenesis from this study, it pro-
vides a paradigm for similar analyses when
the genes at risk in a particular tissue are
eventually known.
In another model system to study
the effect of the transcriptional state of a
protooncogene on its ability to be profi-
ciently repaired, we used the HL60 human
promyelocytic cell line which can be differ-
entiated in vitro, resulting in the transcrip-
tional modulation ofa large class ofgenes.
One of these, the myc protooncogene, is
actively transcribed in the normally grow-
ing undifferentiated promyelocytes. Differ-
entiating the HL60 cells into monocyte/
macrophages down regulates myc gene
expression. When myc is actively tran-
scribed, nearly 60% of the UV-induced
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CPD are removed within 18 hr. However,
when myc is transcriptionally down regu-
lated, only 15% ofthe CPD are removed
in that period. Thus, not only the extent
but also the rate of repair is higher in the
actively transcribed gene. During early dif-
ferentiation, the mycgene is regulated by a
block to transcript elongation at the 5' end
of the first intron. Our results reveal no
significant difference in the rate of CPD
removal between the restriction fragments
upstream and downstream ofthis elonga-
tion block. Furthermore, both strands of
each fragment exhibit similar repair charac-
teristics. In contrast, the constitutively
expressed FMS gene exhibits proficient
removal ofCPD in both the differentiated
and undifferentiated cells. Since efficient
repair ofthe active FMSgene is maintained
in the differentiated cells, the loss ofrepair
competence seen in mycis more likely asso-
ciated with its reduced transcriptional activ-
ity than with a decrease in the overall repair
capacity of the terminally differentiated
cells (20).
Features ofTranscription-
coupled Repair
In studies to further elucidate the nature of
the preferential repair in active genes, we
compared repair in the transcribed and
nontranscribed DNA strands in the DHFR
gene in both CHO and human cells (21).
A genomic fragment of the DHFR gene
was cloned into a vector containing two
phage promoters oriented in opposing
directions so that RNA probes could be
produced to quantify the transcribed and
nontranscribed strands, respectively. These
analyses were then carried out in turn on
the same Southern blot to which the nick-
translated DNA probe had been hybrid-
ized. Although the same frequency ofCPD
was measured initially in each strand, there
was a very significant difference between
the efficiency ofrepair in the two strands.
In the CHO cells nearly 80% ofthe CPD
had been removed from the transcribed
strand within 4 hr while almost no repair
had occurred in the nontranscribed strand.
Similar but less dramatic differences were
evident from the analysis ofstrand-specific
repair in human cells. These findings have
a number ofprofound consequences. First
is the fact that Poisson statistics cannot be
applied with validity to analyze repair in an
active gene because the two DNA strands
do not represent a homogeneous popula-
tion. Second is the implication for mutage-
nesis-the prediction is that one strand
in a given active gene will be much more
subject to mutation than the other. Recent
studies in a number ofother laboratories
have supported this prediction for UV-irra-
diated or chemical carcinogen-treated
mammalian cells.
Transition-coupled repair (TCR) has
now been documented in other cellular
systems including E. coli (22) and Saccha-
romyces cerevisiae (23-25). In yeast it oper-
ates equally well on an expressed gene on a
plasmid as on a chromosome (25). In
eukaryotes it operates on RNA polymerase
II-transcribed genes and requires that the
polymerase is actively elongating on the
template DNA (24-26). RNA polymerase
I-transcribed ribosomal genes are not sub-
ject to TCR (27,28). TCR has been found
to operate generally and with high effi-
ciency throughout the normal mammalian
cell cycle for the DHFR gene that is uni-
formly expressed in all phases of the
human cell cycle. This result was obtained
following UV irradiation ofan asynchro-
nous culture of human fibroblasts using
flow cytometry to sort the population into
G1, early middle and late S, and G2/M
phases, thus avoiding artifacts due to stress-
induced synchronization protocols (29).
These results, incidentally, also rule out
the possible association of a replication-
coupled DNA repair process analogous to
TCR. Clearly, repair is as efficient during
G1 and G2 phases as in S phase for UV-
induced damage in human cells.
Repair of Chemical Adducts
to DNA in the DHFRGene
In contrast to the results for CPD, little
difference in repair rates is seen for N-
methylpurines in the DHFR gene and in a
nontranscribed region located downstream
from it in CHO cells. There are also no
differences in repair between the tran-
scribed and nontranscribed DNA strands
within the gene (30). Thus, the small gly-
cosylase that initiates excision repair ofN-
methylpurines may have uniform access to
the respective strands. The operation of
TCR or not on various other chemical
adducts has been reviewed by Bohr (31).
We have also measured repair ofpso-
ralen monoadducts and interstrand cross-
linking diadducts in the human DHFR
gene and have shown that most of the
DNA cross-linking but only half of the
monoadducts are removed from a 23 Kb
transcribed sequence within 24 hr (15).
More recently we have extended the study
to find that cross-links but not psoralen
monoadducts are susceptible to TCR in
CHO cells (32). Efficient replicative
bypass ofthe persisting monoadducts but
not the cross-links has also been demon-
strated (15). It is likely that most bulky
lesions in mammalian DNA other than
cross-links pose no insurmountable prob-
lems for replication in vivo, but they must
be removed from essential transcribed
sequences to maintain cellular viability.
Persisting damage in unexpressed regions
and silent genes may result in higher levels
of mutation or chromosomal alterations
in those regions of the genome. These
findings have profound implications for
mechanisms of mutagenesis and transfor-
mation as well as risk assessment in relation
to environmental carcinogenesis.
Modelsto Explain Fine-
structure Heterogeneity
in DNA Repair
One can consider a number ofpotential
levels ofexcision-repair enzyme (or enzyme
complex) accessibility to particular lesions
in mammalian DNA. Control at different
levels ofchromatin condensation may con-
strain the repair ofdifferent lesions. Thus,
while CPD are efficiently repaired overall
in human cells, much of the genome in
rodent cells appears to be excluded from
repair, as noted earlier. It is ofinterest in
that regard that in xeroderma pigmento-
sum complementation group C (XP-C),
there also appears to be a relatively large
portion of the genome that is excluded
from repair (33). The XP-C cells are UV
sensitive, unlike rodent cells that are as UV
resistant as normal human cells. However,
the rodent cells can repair 6-4 pyrimidine
pyrimidones and the XP-C cells are
deficient in global repair ofthese important
photoproducts. Venema and co-workers
(34) found that the residual repair capacity
in XP-C was highly selective for active
genes. Similar results were obtained in our
laboratory; we noted very rapid repair in
the active ,-actin and DHFR genes but
poor repair in a silent sequence from the
inactive X chromosome (35). In contrast,
the cells from CS patients are selectively
deficient in the repair of active genes.
Although CS cells are UV sensitive, there is
no deficiency in global DNA repair.
However, the cells are deficient in the
recovery ofUV-inhibited RNA synthesis as
originally reported by Mayne and Lehmann
(36). Venema and co-workers (37)
showed that CS cells are deficient in TCR.
SinceXP-C patients are unusually suscepti-
ble to UV-induced skin cancer but CS
patients are not cancer prone, one might
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speculate that the repair ofthe large silent
domains of the genome is particularly
significant for this particular end point.
It is well established that XP-A is
involved in the recognition ofDNAlesions,
and manyXP-A cell lines are totally devoid
ofrepair ofCPD or 6-4 pyrimidine-pyrim-
idone photoproducts. A partial revertant of
XP-A, XP129 was shown to be as resistant
to UV as normal human cells; 6-4 photo-
product repair was normal but there was
no detectable repair of CPD (38). The
obvious conclusion was that CPD repair
was not important to survival. However,
we showed that repair ofCPD in the tran-
scribed strand ofthe expressed DHFRgene
was as efficient as in normal cells (39).
Thus, the XP129 cells are capable ofTCR,
and the enhanced UV resistance in XP129
cells is due in part to the repair ofCPD in
expressed genes. The repair phenotype of
X129 is the same as that ofrodent cells gen-
erally. They are similarly resistant to UV as
human cells and they repair 6-4 photoprod-
ucts in the overall genome, but they only
repair CPD in expressed genes (39). The
general conclusion is that overall genomic
DNA repair measurements can be mislead-
ing when assessing the importance of
particular lesions to a biological end point.
Detailed models for the mechanism of
TCR have recendy been reviewed (40) and
are beyond the scope ofthis article. All of
the seriously considered models invoke the
stalled RNA polymerase at a lesion as an
antenna to initiate the recruitment of
repair enzymes, as originally suggested by
Mellon et al. (8).
Role of p53 in Tumorigenesis
and in DNA Repair
The p53 tumor suppressor gene product is
essential for mediating the responses of
mammalian cells to DNA-damaging agents.
It is involved in regulation ofthe cell cycle
and in controlling the balance between the
promotion ofsurvival through DNA repair
and the suicidal process ofapoptosis. The
apoptotic pathway ofcell death is probably
important in organs in which severely
damaged cells must be removed to pro-
mote remodeling ofthe affected tissue. It
is less clear how it might be ofvalue to
individual cells in a population.
In damaged cells lacking p53, there
may be a failure to arrest the cell cycle in
G, or to initiate the apoptotic pathway of
cell death. Thus, the cells may attempt
replication of the damaged genome and
accumulate mutations that in turn will
contribute to genomic instability. This is
consistent with the enhanced cancer risk in
patients with LFS. We have investigated
the effect ofmutations in the p53 gene on
UV sensitivity and repair of UV-induced
DNA damage in primary human fibro-
blasts from patients with LFS (41) that are
heterozygous for mutations in one allele of
p53 and sublines expressing only mutant
p53. Spontaneously immortalized deriva-
tives ofthe LFS cell lines have been previ-
ously described (42). The p53-deficient
cells are more resistant to UV cytotoxicity
and exhibit less UV-induced apoptosis than
normal cells or LFS heterozygotes. DNA
repair analysis revealed reduced removal of
CPD from overall genomic DNA in vivo in
the p53 mutant cells compared to the p53
heterozygotes or normal cells. However, the
p53 mutant cells retained the ability to
carry out TCR (41). These results suggest
that loss of p53 function may lead to
greater genomic instability by reducing the
efficiency of DNA repair but that cellular
resistance to DNA-damaging agents may be
enhanced through elimination ofapoptosis.
It thus becomes understandable why
patients defective in p53 would be at
increased riskfor tumorigenesis.
RiskAssessment
For purposes ofrisk assessment, it is some-
times adequate to measure parameters that
are really indicators ofexposure level rather
than directly related to the potentially dele-
terious consequences ofthe exposure; how-
ever, such gross determinations cannot
readily take into account important indi-
vidual variations that may vastly increase
the risks. Therefore, it is important to
learn what factors are significant in the
probability of progression from environ-
mental exposure to an eventual tumor.
The binding of carcinogenic compounds
in tissues does not always correlate with
the tumorigenicity in those tissues, and
a very plausible explanation in some
instances could be that different genes are
at risk in the different tissues because of
their unique patterns of gene expression
and DNA repair, respectively.
It is now clear that the repairability of
damage in mammalian chromatin depends
upon the type oflesion, its precise location
in the genome, and the functional state of
the DNA at that particular site. Information
obtained on the processing ofdamage over-
all or in one domain ofthe genome may not
be relevant to an understanding ofa biologi-
cal response that is dependent upon damage
and repair activity in another domain. Thus,
the question ofwhether protooncogenes are
inefficiently repairable domains in the tis-
sues at risk may therefore have significance
for risk assessment. Since rodents are used
widely in carcinogen testing for human risk
assessment, it is imperative that we learn the
unique features ofDNA damage processing
in the respective systems.
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